SCHEMBL10122095

SCHEMBL10122095

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CN(C)C(=O)N2CCCC2)nn1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.45
TSHR P16473 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.34
CPS1 P31327 1/20 0.33
CCR4 P51679 1/20 0.33
HRH3 Q9Y5N1 2/20 0.33
GAA P10253 2/20 0.33
SCN1A P35498 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
MAPK1 P28482 1/20 0.32
DPP7 Q9UHL4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MCL1 Q07820 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10121857 0.99 GHSR (0.44) GHSRTSHRALDH1A1MAPTCPS1
SCHEMBL10121858 0.90 GHSR (0.46) GHSRTSHRALDH1A1MAPTCCR4
SCHEMBL1709566 0.87 GHSR (0.45) GHSRTSHRALDH1A1MAPTCCR4
SCHEMBL1709573 0.86 GHSR (0.44) GHSRTSHRALDH1A1MAPTCPS1
SCHEMBL10122117 0.86 GHSR (0.47) GHSRCCR4GAASCN1ASCN2A
SCHEMBL10122281 0.86 GHSR (0.56) GHSRTSHRALDH1A1MAPTCPS1
SCHEMBL10122098 0.85 GHSR (0.43) GHSRTSHRALDH1A1MAPTKDM4E
SCHEMBL1709565 0.85 GHSR (0.43) GHSRTSHRALDH1A1MAPTMAPK1
SCHEMBL1709651 0.85 GHSR (0.56) GHSRTSHRALDH1A1MAPTCPS1
SCHEMBL1709656 0.85 DPP7 (0.35) GHSRTSHRALDH1A1MAPTCPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885TSHR 27/4885ALDH1A1 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.